WallStreetZenWallStreetZen

NYSE: DNA
Ginkgo Bioworks Holdings Inc Stock Forecast, Predictions & Price Target

Open Broker Account

Analyst price target for DNA

Based on 7 analysts offering 12 month price targets for Ginkgo Bioworks Holdings Inc.
Min Forecast
$3.00-9.37%
Avg Forecast
$7.41+123.78%
Max Forecast
$14.50+338.07%

Should I buy or sell DNA stock?

Based on 8 analysts offering ratings for Ginkgo Bioworks Holdings Inc.
Buy
Strong Buy
2 analysts 25%
Buy
3 analysts 37.5%
Hold
2 analysts 25%
Sell
1 analysts 12.5%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their DNA stock forecasts and price targets.

DNA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Morgan Stanley
Bottom 6%
6
HoldInitiates Coverage On$5.00+51.06%2022-10-04
BTIG
Top 31%
70
Strong BuyMaintains$6.00+81.27%2022-08-16Find out why
Raymond James
Bottom 24%
24
BuyMaintains$14.50+338.07%2022-08-16Find out why
Jefferies
Top 13%
88
Strong BuyMaintains$4.35+31.42%2022-06-16
Bank of America
Top 6%
95
SellDowngrades$3.00-9.37%2022-05-18
Cowen & Co.
Bottom 1%
1
BuyInitiates Coverage On$12.00+262.54%2022-03-02
Goldman Sachs
Bottom 4%
4
HoldInitiates Coverage On$7.00+111.48%2022-02-23
William Blair
Bottom 8%
8
BuyInitiates Coverage OnN/AN/A2021-10-12

1 of 1

Forecast return on equity

Is DNA forecast to generate an efficient return?
Company
5.81%
Industry
22.46%
Market
122.06%
DNA's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is DNA forecast to generate an efficient return on assets?
Company
4.48%
Industry
13.57%
DNA is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

DNA earnings per share forecast

What is DNA's earnings per share in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
-$0.12
Avg 2 year Forecast
-$0.17
Avg 3 year Forecast
-$0.10

DNA revenue forecast

What is DNA's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$438.0M-31.51%
Avg 2 year Forecast
$396.5M-38%
Avg 3 year Forecast
$716.9M+12.1%
DNA's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

DNA revenue growth forecast

How is DNA forecast to perform vs Biotechnology companies and vs the US market?
Company
3.88%
Industry
23.83%
Market
8.53%
DNA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
DNA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

DNA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
DNA$3.31$7.41+123.78%Buy
HALO$41.66$52.00+24.82%Strong Buy
LEGN$41.01$64.75+57.89%Strong Buy
ASND$113.46$149.30+31.59%Strong Buy
APLS$57.69$78.75+36.51%Buy

Ginkgo Bioworks Holdings Stock Forecast FAQ

Is Ginkgo Bioworks Holdings Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 8 Wall Street analysts covering (NYSE: DNA) stock is to Buy DNA stock.

Out of 8 analysts, 2 (25%) are recommending DNA as a Strong Buy, 3 (37.5%) are recommending DNA as a Buy, 2 (25%) are recommending DNA as a Hold, 1 (12.5%) are recommending DNA as a Sell, and 0 (0%) are recommending DNA as a Strong Sell.

If you're new to stock investing, here's how to buy Ginkgo Bioworks Holdings stock.

What is DNA's earnings growth forecast for 2022-2024?

(NYSE: DNA) Ginkgo Bioworks Holdings's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 8.86%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 16.88%.

Ginkgo Bioworks Holdings's earnings in 2022 is -$2,961,867,000.On average, 2 Wall Street analysts forecast DNA's earnings for 2022 to be -$214,179,938, with the lowest DNA earnings forecast at -$267,724,923, and the highest DNA earnings forecast at -$160,634,954. On average, 3 Wall Street analysts forecast DNA's earnings for 2023 to be -$303,421,579, with the lowest DNA earnings forecast at -$553,298,173, and the highest DNA earnings forecast at -$71,393,313.

In 2024, DNA is forecast to generate -$178,483,282 in earnings, with the lowest earnings forecast at -$392,663,220 and the highest earnings forecast at $17,848,328.

What is DNA's revenue growth forecast for 2022-2024?

(NYSE: DNA) Ginkgo Bioworks Holdings's forecast annual revenue growth rate of 3.88% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 23.83%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 8.53%.

Ginkgo Bioworks Holdings's revenue in 2022 is $639,503,000.On average, 1 Wall Street analysts forecast DNA's revenue for 2022 to be $781,756,773,846, with the lowest DNA revenue forecast at $781,756,773,846, and the highest DNA revenue forecast at $781,756,773,846. On average, 3 Wall Street analysts forecast DNA's revenue for 2023 to be $707,625,527,625, with the lowest DNA revenue forecast at $581,855,498,342, and the highest DNA revenue forecast at $910,264,736,670.

In 2024, DNA is forecast to generate $1,279,546,646,507 in revenue, with the lowest revenue forecast at $1,179,417,525,474 and the highest revenue forecast at $1,379,675,767,541.

What is DNA's forecast return on assets (ROA) for 2022-2025?

(NYSE: DNA) forecast ROA is 4.48%, which is lower than the forecast US Biotechnology industry average of 13.57%.

What is DNA's Price Target?

According to 7 Wall Street analysts that have issued a 1 year DNA price target, the average DNA price target is $7.41, with the highest DNA stock price forecast at $14.50 and the lowest DNA stock price forecast at $3.00.

On average, Wall Street analysts predict that Ginkgo Bioworks Holdings's share price could reach $7.41 by Oct 4, 2023. The average Ginkgo Bioworks Holdings stock price prediction forecasts a potential upside of 123.78% from the current DNA share price of $3.31.

What is DNA's Earnings Per Share (EPS) forecast for 2022-2024?

(NYSE: DNA) Ginkgo Bioworks Holdings's current Earnings Per Share (EPS) is -$2.03. On average, analysts forecast that DNA's EPS will be -$0.12 for 2022, with the lowest EPS forecast at -$0.15, and the highest EPS forecast at -$0.09. On average, analysts forecast that DNA's EPS will be -$0.17 for 2023, with the lowest EPS forecast at -$0.31, and the highest EPS forecast at -$0.04. In 2024, DNA's EPS is forecast to hit -$0.10 (min: -$0.22, max: $0.01).

What is DNA's forecast return on equity (ROE) for 2022-2025?

(NYSE: DNA) forecast ROE is 5.81%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.